title: Why are clinically indicated, but lower-risk, patients less likely to receive implantable cardioverter-defibrillator and cardiac resynchronization therapy?
authors.affiliation: Clinical Electrophysiology, Division of Cardiology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina. Electronic address: paul_mounsey@med.unc.edu.
authors.forename: J Paul
authors.initials: JP
authors.lastname: Mounsey
authors.affiliation: Clinical Electrophysiology, Division of Cardiology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
authors.forename: Jennifer D
authors.initials: JD
authors.lastname: Schwartz
mesh_terms: D058406:Cardiac Resynchronization Therapy / Q000639:trends*; D006333:Heart Failure / Q000628:therapy*; D006801:Humans; D017711:Nonlinear Dynamics; D013223:Statistics as Topic / Q000639:trends*
keywords: cardiac resynchronization therapy; follow-up studies; survival